Kaya Kvarme Jacobsen

Kaya Kvarme Jacobsen

Auto-generated profile, based on publicly available information

Kaya Kvarme Jacobsen

Department of Clinical Medicine, University of Bergen, Bergen, Norway

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2015 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Verified
Journal Article
Open access
PDF file
KJKaya K. Jacobsen
Kaya K. Jacobsen
RKRune Kleppe
Rune Kleppe
SJStefan Johansson
Stefan Johansson
TZTetyana Zayats
Tetyana Zayats
JHJan Haavik
Jan Haavik
Monoamines critically modulate neurophysiological functions affected in several neuropsychiatric disorders. We therefore examined genes encoding key enzymes of catecholamine and serotonin biosynthesis (tyrosine and tryptophan hydroxylases—TH and TPH1/2) as well as their regulatory 14‐3‐3 proteins (encoded byYWHA‐genes). Previous studies have focused mainly on the individual genes, but no analysis spanning this regulatory network has been reported. We explored interactions between these genes in Norwegian patients with adult attention deficit hyperactivity disorder (aADHD), followed by gene‐complex association tests in four major neuropsychiatric conditions; childhood ADHD (cADHD), bipolar disorder, schizophrenia, and major depressive disorder. For interaction analyses, we evaluated 55 SNPs across these genes in a sample of 583 aADHD patients and 637 controls. For the gene‐complex tests, we utilized the data from large‐scale studies of The Psychiatric Genomics Consortium (PGC). The four major neuropsychiatric disorders were examined for association with each of the genes individually as well as in three complexes as follows: (1)TPH1andYWHA‐genes; (2)TH,TPH2andYWHA‐genes; and (3) all genes together. The results show suggestive epistasis betweenYWHAEand two other 14‐3‐3‐genes ‐YWHAZ, YWHAQ ‐in aADHD (nominalP‐value of 0.0005 and 0.0008, respectively). In PGC data, association betweenYWHAEand schizophrenia was noted (P = 1.00E‐05), whereas the combination ofTPH1andYWHA‐genes revealed signs of association in cADHD, schizophrenia, and bipolar disorder. In conclusion, polymorphisms in theYWHA‐genes and their targets may exert a cumulative effect in ADHD and related neuropsychiatric conditions, warranting the need for further investigation of these gene‐complexes. © 2015 The Authors.American Journal of Medical Genetics Part B: Neuropsychiatric GeneticsPublished by Wiley Periodicals, Inc.

1 October 2024 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
KJKaya Kvarme Jacobsen
Kaya Kvarme Jacobsen
LLLene Bjerke Laborie
Lene Bjerke Laborie
HKHege Kristiansen
Hege Kristiansen
ASAnnette Schäfer
Annette Schäfer
TGTrude Gundersen
Trude Gundersen
KRKaren Rosendahl
Karen Rosendahl
Background: Developmental dysplasia of the hip (DDH) is a congenital condition affecting 2–3% of all newborns. DDH increases the risk of osteoarthritis and is the cause of 30% of all total hip arthroplasties in adults < 40 years of age. We aim to explore the genetic background of DDH in order to improve diagnosis and personalize treatment. Methods: We conducted a structured literature review using PRISMA guidelines searching the Medline, Embase and Cochrane databases. We included 31 case control studies examining single nucleotide polymorphisms (SNPs) in non-syndromic DDH. Results: A total of 73 papers were included for full text review, of which 31 were single nucleotide polymorphism (SNP) case/control association studies. The literature review revealed that the majority of published papers on the genetics of DDH were mostly underpowered for detection of any significant association. One large genome wide association study has been published (N = 9,915), establishing GDF5 as a plausible risk factor. Conclusions: DDH is known to be congenital and heritable, with family occurrence of DDH already included as a risk factor in most screening programs. Despite this, high quality genetic research is scarce and no genetic risk factors have been soundly established, prompting the need for more research.

16 December 2023 in Osteoarthritis and Cartilage Open
Verified
Journal Article
Open access
KJKaya Kvarme Jacobsen
Kaya Kvarme Jacobsen
SBSigrid Børte
Sigrid Børte
LLLene Bjerke Laborie
Lene Bjerke Laborie
HKHege Kristiansen
Hege Kristiansen
ASAnnette Schäfer
Annette Schäfer
KRKaren Rosendahl
Karen Rosendahl
Developmental dysplasia of the hip (DDH) is a congenital condition affecting 2–3% of all infants. DDH increases the risk of osteoarthritis, is the cause of 30 ​% of all total hip arthroplasties (THAs) in adults <40 years of age and can result in loss of life quality. Our aim was to explore the genetic background of DDH in order to improve diagnosis, management and longterm outcome. We used the large, ongoing, longitudinal Trøndelag Health Study (HUNT) database. Case definition was based on ICD-9/-10 diagnoses of DDH, or osteoarthritis secondary to DDH. Analyses were performed using SAIGE software, with covariates including sex, batch, birth year and principal components. We included only single nucleotide polymorphisms (SNPs) with minor allele frequency (MAF) ≥ 0.01, R2≥ 0.8 and Hardy-Weinberg equilibrium (HWE) P-value ≥ 0.0001. Significance level was set at p ​< ​5 ​× ​10−8. Meta-analysis using data from DDH and primary osteoarthritis genome-wide association studies (GWASs) was done using METAL software. The study was approved by the regional ethical committee. Analysis included 69,500 individuals, of which 408 cases, and 8,531,386 SNPs. Two SNPs near COL11A1 were significantly associated with DDH; rs713162 (β ​= ​−0.43, SE ​= ​0.07, p ​= ​8.4 ​× ​10−9) and rs6577334 (β ​= ​−0.43, SE ​= ​0.08, p ​= ​8.9 ​× ​10−9). COL11A1 has previously been associated with acetabular dysplasia and osteoarthritis. Meta-analysis supported previous GWAS findings of both DDH and primary osteoarthritis. This large, genome-wide case-control study indicates an association between COL11A1 and DDH and is an important contribution to investigating the etiology of DDH, with further research needed.